Bridgefront Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Buy |
+6,724
| New | +$370K | 0.1% | 355 |
|
|
2024
Q4 | – | Sell |
-8,235
| Closed | -$579K | – | 592 |
|
|
2024
Q3 | $579K | Buy |
+8,235
| New | +$579K | 0.22% | 146 |
|
|
2022
Q2 | – | Sell |
-4,407
| Closed | -$340K | – | 309 |
|
|
2022
Q1 | $340K | Buy |
+4,407
| New | +$340K | 0.42% | 75 |
|
|
2021
Q4 | – | Sell |
-5,623
| Closed | -$435K | – | 310 |
|
|
2021
Q3 | $435K | Buy |
5,623
+3,031
| +117% | +$234K | 0.45% | 56 |
|
|
2021
Q2 | $216K | Buy |
+2,592
| New | +$216K | 0.08% | 481 |
|